Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic.
about
Polymer therapeutics in surgery: the next frontierPhase I and pharmacokinetic (PK) study of MAG-CPT (PNU 166148): a polymeric derivative of camptothecin (CPT)Targeting angiogenesis-dependent calcified neoplasms using combined polymer therapeuticsTemperature-sensitive magnetic drug carriers for concurrent gemcitabine chemohyperthermia.Recent trends in targeted anticancer prodrug and conjugate design.Synthesis and characterization of biodegradable HPMA-oligolysine copolymers for improved gene deliveryEnzyme-directed assembly of a nanoparticle probe in tumor tissueMicrobial biosynthesis of polyglutamic acid biopolymer and applications in the biopharmaceutical, biomedical and food industries.Drug targeting by macromolecules without recognition unit?Strategies for targeting protein therapeutics to selected tissues and cells.Polymer genomics: an insight into pharmacology and toxicology of nanomedicinesNanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer.Design, synthesis and applications of hyaluronic acid-paclitaxel bioconjugates.Nanoparticles containing insoluble drug for cancer therapy.Classification of stimuli-responsive polymers as anticancer drug delivery systems.Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers.Noncovalent interaction-assisted polymeric micelles for controlled drug delivery.Role of polymer-drug conjugates in organ-specific delivery systems.Drug-conjugated polymers as gene carriers for synergistic therapeutic effect.Synthesis and Structural Characterization of Bioactive PHA and γ-PGA Oligomers for Potential Applications as a Delivery System.Tumor-specific delivery and therapy by double-targeted DTX-CMCS-PEG-NGR conjugates.Preparation and antitumor activity of bFGF-mediated active targeting doxorubicin microbubbles.Distribution of amphotericin B-arabinogalactan conjugate in mouse tissue and its therapeutic efficacy against murine aspergillosis.Fully degradable hydrophilic polyals for protein modification.Synthesis of a macromolecular camptothecin conjugate with dual phase drug release.Poly(2-alkylacrylic acid) polymers deliver molecules to the cytosol by pH-sensitive disruption of endosomal vesicles.The cytoplasmic escape and nuclear accumulation of endocytosed and microinjected HPMA copolymers and a basic kinetic study in Hep G2 cells.Comparison of hydrazone heterobifunctional cross-linking agents for reversible conjugation of thiol-containing chemistry.Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systems.Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470.Conjugation of Paclitaxel to Hybrid Peptide Carrier and Biological Evaluation in Jurkat and A549 Cancer Cell Lines.Induction of interleukin-1beta, tumour necrosis factor-alpha and apoptosis in mouse organs by amphotericin B is neutralized by conjugation with arabinogalactan.Novel Gemcitabine Conjugated Albumin Nanoparticles: a Potential Strategy to Enhance Drug Efficacy in Pancreatic Cancer Treatment.Hybrid Nanoparticles as Drug Carriers for Controlled Chemotherapy of Cancer.HPMA copolymer-phospholipase C and dextrin-phospholipase A2 as model triggers for polymer enzyme liposome therapy (PELT).Modifications of quinolones and fluoroquinolones: hybrid compounds and dual-action molecules.Hydroxypropylcellulose-aceclofenac conjugates: high covalent loading design, structure characterization, nano-assemblies and thermal kinetics
P2860
Q28067866-7F1E9907-8D63-45DF-9465-24767875FD9FQ33361186-A18703F7-9BC7-4E27-B5C2-35FA59BA3AE3Q33432776-CDF4EDC4-B6B3-42E6-B384-D7D946E0E236Q33561078-D46DEF5E-F1D2-4CCB-B77E-F71436D3AA68Q33573762-17C634EF-A853-4E4F-BD61-A334A8BFE3D1Q33601685-52B8938F-6D64-4106-918D-21BF3B25FCA8Q33940322-6A53E7E0-8669-49AE-B764-74F73730CF37Q34653663-10E0DC49-DC9D-4DB0-B298-1D22AEA63E20Q35549416-09B63836-CFFC-4237-8A0D-EDF135366D06Q35609785-F75117A7-3E7D-4932-8F4C-02DF6E09563FQ35754353-088C9B66-FA9B-4544-96A6-B4283D56C2AAQ36953404-91963327-ABFA-49CE-BDF8-8F5BE27F22C4Q37096500-9534E53A-5A80-4864-968C-C7F50B74B78CQ37693046-1789850A-890A-41FB-AA2E-FEF9DA92F945Q38189091-1C7CCBB3-193C-4D9A-AB3D-AB5609B3EEECQ38207696-B06D0388-783B-4636-BECC-FB6F75912A4DQ38227515-94447D1D-F879-46A9-9179-FA3426E1AC08Q38365556-B7DBC95D-D3F7-48CC-814E-B12B3937F686Q38608253-AF359A85-2661-4B2B-B2FC-59B6116B3DCEQ38643305-F671E08E-B61A-49BA-A4F3-92B9FBA40B63Q39094877-25FC6798-4E22-49AB-885E-DF3977B253DDQ39260427-57F90776-A383-4BAA-92A7-8899C8C125CBQ39955259-E7F5481B-21D8-4E9E-BC6A-4D05E210CA61Q40223801-69CAFAB1-1453-4937-8DE8-FCB162A2F03FQ40239624-AAF948CB-76F8-4557-B576-DF09DB23E43EQ40605445-2C511488-2C52-46F2-9A83-F54B2D430EC4Q42064010-98B13E45-1E82-4DD5-935D-1DD2EE695B7CQ42407631-70C88051-9DD8-4B2D-BA38-27AEF3810DBEQ44541620-80B4E0B2-5490-4C2F-BEF6-A36A064E43D6Q44775111-ABFA3658-B488-4EE7-9003-759AE156845FQ44910150-6CB5BC14-4D38-4C6F-B3AF-76C511183657Q46425791-FEA424D0-522D-45B8-AD98-698C36FAFFDAQ48696930-38243560-3A59-411C-8BBE-0BF8DB485864Q50633549-8285B251-70CA-4951-ACA9-5183F3F89A51Q50879676-4BE96AAD-F973-44D2-BBFE-6094F7F9C42FQ55407405-99F50E01-BD16-4477-93AE-2273B1BA5525Q57348127-2DB69FD0-A1FD-460C-83FE-63D00C2A8494
P2860
Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Polymer-drug conjugates, PDEPT ...... from the laboratory to clinic.
@en
Polymer-drug conjugates, PDEPT ...... from the laboratory to clinic.
@nl
type
label
Polymer-drug conjugates, PDEPT ...... from the laboratory to clinic.
@en
Polymer-drug conjugates, PDEPT ...... from the laboratory to clinic.
@nl
prefLabel
Polymer-drug conjugates, PDEPT ...... from the laboratory to clinic.
@en
Polymer-drug conjugates, PDEPT ...... from the laboratory to clinic.
@nl
P2093
P1476
Polymer-drug conjugates, PDEPT ...... from the laboratory to clinic.
@en
P2093
P304
P356
10.1016/S0168-3659(01)00328-5
P407
P577
2001-07-01T00:00:00Z